PSC Capital Partners LLC 13D and 13G filings for Akoya Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 09:11 am Purchase | 2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 3,517,360 7.200% | 800,000 (+29.44%) | Filing |
| 2023-02-15 09:15 am Unchanged | 2022-12-31 | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 2,717,360 7.200% | 0 (Unchanged) | Filing |
| 2023-02-14 3:47 pm Sale | 2022-12-31 | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 2,717,360 7.200% | -96,411 (-3.43%) | Filing |
| 2022-02-25 10:57 am Purchase | 2021-12-31 | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 2,813,771 7.600% | 2,813,771 (New Position) | Filing |
| 2022-02-14 12:56 pm Purchase | 2021-12-31 | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 2,813,771 7.600% | 2,813,771 (New Position) | Filing |